CME Group Inc. (CME) 10-K Red Flags
Risk signals extracted deterministically from CME Group Inc.’s SEC 10-K/10-Q XBRL filings — no LLM, every finding cites the underlying data.
Detected red flags (7)
- Endogenous analysis: No significant implicit signals detected in the latest filing. Key metrics are changing within normal ranges — the filing appears consistent with prior-period patterns.
- 8 new XBRL disclosure(s) in latest filing — expanding reporting scope.
- 20 disclosure(s) dropped from prior year — reduced reporting granularity.
- Price $236.60 — downtrend (below 200-DMA); 1-month momentum negative.
- RSI(14) 33.24.
- Composite risk: Elevated.
- Liquidity current ratio 1.02 (adequate).
Filings & ownership
- Latest annual report (10-K) filed Feb 26, 2026.
- Latest quarterly report (10-Q) filed Apr 24, 2026.
- 11 recent 8-K material-event filings in the index.
- Recent insider Form 4s: 0 buy vs 0 sell transactions.
- ~10,000+ recent 13F-HR filings reference CME Group Inc.; broad institutional reporting.
- Recent filers include MARK MORRIS ET AL, WINNOW WEALTH LLC, Walleye Trading LLC.
- 1 recent 13D activist/beneficial-ownership filings — potential catalyst.
- 19 recent 13G passive institutional ownership notices.
Full CME analyst report
Valuation (DCF & Graham), technicals, macro exposure, risk scorecard and 13F/13D ownership.
View full report →Not investment advice. FilingSight is an automated analytical research tool, not a registered investment advisor. Ratings and scores are quantitative analytical classifications, not buy or sell recommendations. Nothing here is personalized to your circumstances. Investing involves risk of loss — consult a licensed professional. See full disclosures.